
Health & Lifestyle
ASCI finds all 60 reviewed supplement ads broke its code
ASCI's report released on October 28, 2026 found all 60 completed nutraceutical ad cases from July to September made claims without adequate proof.
30 Oct 2026, 19:11 IST
Peepals Sanskriti · Topic
3 stories, newest first

ASCI's report released on October 28, 2026 found all 60 completed nutraceutical ad cases from July to September made claims without adequate proof.

FSSAI said on October 19, 2026 it had sent notices to Zepto over expired besan and to three firms over labels and unapproved health claims on cranberry capsules and a snack.

On October 8, 2026, FSSAI sent show-cause notices to Dr Reddy's, Nestle Health Science and online sellers over health claims for the GLP-1-linked supplement Celevida GLP+.
The most important, fact-checked stories from all seven publications, once a week.